Clinical Trials Browser

INDUSTRY × Head and Neck Neoplasms × imgatuzumab × Clear all

NCT01046266 2016-09-14

A Study of Pharmacodynamics of RO5083945 in Patients With Head and Neck Squamous Cell Carcinoma

Phase 1 Completed

Head and Neck Neoplasms